At a glance
ClinicalIndex Comparison RecordN/ACompleted· 375 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Humira® for Subcutaneous Injection Special Investigation ( All-case Survey ) in Patients With Juvenile Idiopathic Arthritis Study
In Brief
An observational study for Arthritis, Juvenile Rheumatoid. Completed, enrolled 375 participants.
Detailed Summary
This study of Humira will be conducted to clarify the following with regard to the treatment of juvenile idiopathic arthritis affecting multiple joints with this drug: * Unknown adverse drug reactions (especially important adverse drug reactions) * Incidence and conditions of occurrence of adverse reactions in the clinical setting * Factors that may affect the safety and effectiveness of Humira
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Juvenile Rheumatoid
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2011
First PostedAug 2011
Primary CompletionApr 2018
TodayJul 2026
First PostedAug 8, 2011
Enrollment StartJul 1, 2011
Primary CompletionApr 2, 2018
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 14.9 years ago